| Year | Title | Author(s) |
| 2024 |
TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trial
Frontiers In Immunology |
Bazile, C Malik, MMA Ackeifi, C Anderson, RL Beck, RW Donath, MY Dutta, S Hedrick, JA Karpen, SR Kay, TWH Marder, T Marinac, M McVean, J Meyer, R Pettus, J Quattrin, T Verstegen, RHJ Vieth, JA Latres, E |
| 2018 |
Defining Outcomes for -cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop
Transplantation |
Rickels, MR Stock, PG de Koning, EJP Piemonti, L Pratschke, J Alejandro, R Bellin, MD Berney, T Choudhary, P Johnson, PR Kandaswamy, R Kay, TWH Keymeulen, B Kudva, YC Latres, E Langer, RM Lehmann, R Ludwig, B Markmann, JF Marinac, M Odorico, JS Pattou, F Senior, PA Shaw, JAM Vantyghem, MC White, S |